Text Size

The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
St. Joseph's Healthcare Hamilton
ClinicalTrials.gov Identifier:
NCT00292877
First received: February 15, 2006
Last updated: January 21, 2011
Last verified: January 2011
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
No publications provided by St. Joseph's Healthcare Hamilton

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):